NRX Pharmaceuticals, Inc. short interest in 2021
In 2021, NRX Pharmaceuticals, Inc.'s disclosed short interest ran from 5.29% of shares outstanding on 15 Jul 2021 to 3.80% on 31 Dec 2021, a change of -1.49 percentage points. The year's high was 5.29% on 15 Jul 2021 and its low 2.01% on 15 Nov 2021, averaging 3.70% across 10 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 1.41 days on 30 Sep 2021. Full history: NRX Pharmaceuticals, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 5.29% (15 Jul 2021)
- End of year
- 3.80% (31 Dec 2021)
- Change
- -1.49 pp
- High
- 5.29% (15 Jul 2021)
- Low
- 2.01% (15 Nov 2021)
- Average
- 3.70%
- Highest days to cover
- 1.41 (30 Sep 2021)
- SEC filings marked
- 4
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jul 2021 | 5.29% | 1.00 | 10-K filed, 10-Q filed |
| 31 Aug 2021 | 4.65% | 1.00 | 10-Q filed |
| 15 Sep 2021 | 4.43% | 1.28 | |
| 30 Sep 2021 | 3.50% | 1.41 | |
| 15 Oct 2021 | 3.93% | 1.00 | |
| 29 Oct 2021 | 3.44% | 1.30 | |
| 15 Nov 2021 | 2.01% | 1.00 | 10-Q filed |
| 30 Nov 2021 | 3.26% | 1.00 | |
| 15 Dec 2021 | 2.71% | 1.00 | |
| 31 Dec 2021 | 3.80% | 1.26 |
See also: NRX Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.